EDGAR Filing Documents for 0001213900-20-036383

Form 8-K - Current report:

SEC Accession No. 0001213900-20-036383

Filing Date

2020-11-12

Accepted

2020-11-12 09:01:27

Documents

Period of Report

2020-11-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea129454-8k_180lifescience.htm	8-K	104853
2	SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT	ea129454ex3-1_180lifesci.htm	EX-3.1	354712
3	FORM OF LOCK-UP AGREEMENT	ea129454ex10-1_180lifesci.htm	EX-10.1	43160
4	ESCROW AGREEMENT DATED NOVEMBER 6, 2020 BY AND BETWEEN THE REGISTRANT, CONTINENT	ea129454ex10-2_180lifesci.htm	EX-10.2	83842
5	2020 OMNIBUS INCENTIVE PLAN	ea129454ex10-3_180lifesci.htm	EX-10.3	114261
6	EMPLOYMENT AGREEMENT, DATED JULY 1, 2020 BY AND BETWEEN 180 LIFE CORP. (F/K/A 18	ea129454ex10-4_180lifesci.htm	EX-10.4	44977
7	FIRST AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN 180 LIFE CORP. (F/K/A 180	ea129454ex10-5_180lifesci.htm	EX-10.5	13455
8	AUDITED FINANCIAL STATEMENTS OF 180 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019	ea129454ex99-1_180lifesci.htm	EX-99.1	442870
9	UNAUDITED FINANCIAL STATEMENTS OF 180 FOR THE SIX MONTHS ENDED JUNE 30, 2020 AND	ea129454ex99-2_180lifesci.htm	EX-99.2	274012
10	AUDITED FINANCIAL STATEMENTS OF CANNBIOREX PHARMACEUTICALS CORP. FOR THE PERIOD	ea129454ex99-3_180lifesci.htm	EX-99.3	216531
11	UNAUDITED FINANCIAL STATEMENTS OF CANNBIOREX PHARMACEUTICALS CORP. FOR THE SIX M	ea129454ex99-4_180lifesci.htm	EX-99.4	151169
12	AUDITED FINANCIAL STATEMENTS OF 180 THERAPEUTICS L.P. FOR THE FISCAL YEARS ENDED	ea129454ex99-5_180lifesci.htm	EX-99.5	118267
13	UNAUDITED FINANCIAL STATEMENTS OF 180 THERAPEUTICS L.P. FOR THE SIX MONTHS ENDED	ea129454ex99-6_180lifesci.htm	EX-99.6	88477
14	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS FOR THE YEAR ENDED D	ea129454ex99-7_180lifesci.htm	EX-99.7	364736
15	NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER	ea129454ex99-8_180lifesci.htm	EX-99.8	18691
	Complete submission text file	0001213900-20-036383.txt		2435673

Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019

Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555

180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)